Loading clinical trials...
Loading clinical trials...
The main aim of the study is to investigate the possible long-term therapeutic effects of psilocybin on the symptoms of severe depression, as well as the brain mechanisms underlying these changes. Dep...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Helsinki
Collaborators
NCT04618250 · Psychiatric Disorder, Schizophrenia, and more
NCT03922425 · Bipolar Disorder, Schizophrenia, and more
NCT03837340 · Severe Mental Disorders, Schizophrenia, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions